ArticleJournal of clinical pharmacology2020

Population Pharmacokinetics and Exposure-Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder.

Bojan Lalovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.